SI-BONE Management

Management criteria checks 3/4

SI-BONE's CEO is Laura Francis, appointed in Apr 2021, has a tenure of 3.58 years. total yearly compensation is $3.71M, comprised of 16.8% salary and 83.2% bonuses, including company stock and options. directly owns 0.82% of the company’s shares, worth $4.18M. The average tenure of the management team and the board of directors is 3.6 years and 13.9 years respectively.

Key information

Laura Francis

Chief executive officer

US$3.7m

Total compensation

CEO salary percentage16.8%
CEO tenure3.6yrs
CEO ownership0.8%
Management average tenure3.6yrs
Board average tenure13.9yrs

Recent management updates

Recent updates

Market Cool On SI-BONE, Inc.'s (NASDAQ:SIBN) Revenues

Nov 04
Market Cool On SI-BONE, Inc.'s (NASDAQ:SIBN) Revenues

Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?

Sep 25
Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?

SI-BONE, Inc.'s (NASDAQ:SIBN) P/S Is On The Mark

Apr 01
SI-BONE, Inc.'s (NASDAQ:SIBN) P/S Is On The Mark

Analyst Estimates: Here's What Brokers Think Of SI-BONE, Inc. (NASDAQ:SIBN) After Its Full-Year Report

Feb 29
Analyst Estimates: Here's What Brokers Think Of SI-BONE, Inc. (NASDAQ:SIBN) After Its Full-Year Report

Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

Feb 28
Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?

Nov 12
Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?

Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?

Aug 09
Is SI-BONE (NASDAQ:SIBN) Using Too Much Debt?

Is SI-BONE (NASDAQ:SIBN) A Risky Investment?

Apr 20
Is SI-BONE (NASDAQ:SIBN) A Risky Investment?

Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

Jan 01
Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

Sep 24
Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

SI-BONE (NASDAQ:SIBN) Has Debt But No Earnings; Should You Worry?

Apr 19
SI-BONE (NASDAQ:SIBN) Has Debt But No Earnings; Should You Worry?

Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

Jan 05
Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

Oct 05
Is SI-BONE (NASDAQ:SIBN) Using Debt In A Risky Way?

CEO Compensation Analysis

How has Laura Francis's remuneration changed compared to SI-BONE's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$37m

Jun 30 2024n/an/a

-US$41m

Mar 31 2024n/an/a

-US$43m

Dec 31 2023US$4mUS$622k

-US$43m

Sep 30 2023n/an/a

-US$44m

Jun 30 2023n/an/a

-US$48m

Mar 31 2023n/an/a

-US$55m

Dec 31 2022US$5mUS$604k

-US$61m

Sep 30 2022n/an/a

-US$65m

Jun 30 2022n/an/a

-US$66m

Mar 31 2022n/an/a

-US$62m

Dec 31 2021US$3mUS$527k

-US$57m

Sep 30 2021n/an/a

-US$51m

Jun 30 2021n/an/a

-US$45m

Mar 31 2021n/an/a

-US$43m

Dec 31 2020US$2mUS$386k

-US$44m

Sep 30 2020n/an/a

-US$44m

Jun 30 2020n/an/a

-US$46m

Mar 31 2020n/an/a

-US$42m

Dec 31 2019US$2mUS$375k

-US$38m

Sep 30 2019n/an/a

-US$35m

Jun 30 2019n/an/a

-US$28m

Mar 31 2019n/an/a

-US$23m

Dec 31 2018US$734kUS$319k

-US$17m

Sep 30 2018n/an/a

-US$17m

Jun 30 2018n/an/a

-US$18m

Mar 31 2018n/an/a

-US$21m

Dec 31 2017US$518kUS$302k

-US$23m

Compensation vs Market: Laura's total compensation ($USD3.71M) is above average for companies of similar size in the US market ($USD2.18M).

Compensation vs Earnings: Laura's compensation has been consistent with company performance over the past year.


CEO

Laura Francis (57 yo)

3.6yrs

Tenure

US$3,713,871

Compensation

Ms. Laura A. Francis, MBA, serves as Chief Executive Officer and Director at SI-BONE, Inc. since April 18, 2021. She was Chief Financial Officer of SI-Bone Inc. since May 26, 2015 until April 18, 2021 and...


Leadership Team

NamePositionTenureCompensationOwnership
Laura Francis
CEO & Director3.6yrsUS$3.71m0.82%
$ 4.2m
Anshul Maheshwari
Chief Financial Officer3.6yrsUS$1.86m0.16%
$ 821.9k
Anthony Recupero
President of Commercial Operations8.3yrsUS$2.06m0.23%
$ 1.2m
Jeff Bertolini
Senior Vice President of Operations & Information Technology2.3yrsno datano data
Scott Yerby
Senior VP of Engineering & CTOno datano datano data
Saqib Iqbal
Director of FP&A and Investor Relationsno datano datano data
Michael Pisetsky
Chief Business & Legal Affairs Officer8.3yrsno datano data
Aimee Einstein
Vice President of People & Culture2.8yrsno datano data
Daniel Cher
Senior Vice President of Clinical & Regulatory Affairs3.4yrsno datano data
W. Reckling
Chief Medical Officer & VP of Medical Affairsno datano datano data
Nikolas Kerr
Senior Vice President of Product3.6yrsno datano data
Troy Wahlenmaier
Senior Vice President of US Salesless than a yearno datano data

3.6yrs

Average Tenure

56.5yo

Average Age

Experienced Management: SIBN's management team is considered experienced (3.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Laura Francis
CEO & Director3.6yrsUS$3.71m0.82%
$ 4.2m
Timothy Davis
Lead Independent Director16.6yrsUS$211.30k0.092%
$ 469.0k
Gregory Hinckley
Independent Director13.8yrsUS$191.30k0.38%
$ 1.9m
Jeryl Hilleman
Independent Director4.9yrsUS$206.30k0.025%
$ 127.4k
John Freund
Independent Director11.8yrsUS$188.30k0.31%
$ 1.6m
Ralph Rashbaum
Member of Medical Advisory Board14.8yrsno datano data
Steven Garfin
Member of Medical Advisory Board14.8yrsno datano data
Frank Phillips
Member of Medical Advisory Board14.8yrsno datano data
Jeffrey Dunn
Executive Chairman16.6yrsUS$551.18k0.25%
$ 1.3m
A. Shamie
Member of Medical Advisory Board13.9yrsno datano data
Mika Nishimura
Independent Director3.7yrsUS$188.30k0.046%
$ 235.1k
Jonathan Hyde
Member of Surgeon Advisory Boardno datano datano data

13.9yrs

Average Tenure

67yo

Average Age

Experienced Board: SIBN's board of directors are seasoned and experienced ( 13.9 years average tenure).